Crossmark

Clinical usefulness of the serum levels of neuroinflammatory and lung fibrosis biomarkers in the assessment of cognitive dysfunction in post-COVID19 patients

Crossref DOI link: https://doi.org/10.1038/s41598-024-76630-4

Published Online: 2024-10-28

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Kulczyńska-Przybik, Agnieszka

Czupryna, Piotr

Adamczuk, Justyna

Kruszewska, Ewelina

Mroczko, Barbara

Moniuszko-Malinowska, Anna
Funding

Funding for this research was provided by:

Medical University of Białystok, Poland
License Information

Text and Data Mining valid from 2024-10-28

Version of Record valid from 2024-10-28
More Information

Article History

Received: 22 February 2024

Accepted: 15 October 2024

First Online: 28 October 2024

Declarations

:

: The authors declare no competing interests.

Document is current

Any future updates will be listed below